Compare iShares Core MSCI EAFE ETF (IEFA) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI EAFE ETF vs Lam Research Corporation — how do they compare? iShares Core MSCI EAFE ETF trades at $96.52 (market cap $189.19B), while Lam Research Corporation trades at $318.84 (market cap $401.19B). The key difference: Lam Research Corporation is far larger — about 2.1× iShares Core MSCI EAFE ETF's market cap, and Lam Research Corporation pays a 0.41% dividend while iShares Core MSCI EAFE ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 40 Days and Lam Research Corporation for 60 Days on average.
| IEFA | LRCX | |
|---|---|---|
Market Cap | $189.19B | $401.19B |
Volume | 8,441,787 | 8,960,892 |
Sector | Broad Market / Factor | Technology |
52-Week High | $101.41 | $433.33 |
52-Week Low | $85.06 | $131.37 |
Typical Hold Time | 40 Days | 60 Days |
Enterprise Value | — | $399.35B |
Dividend Yield | — | 0.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEFA, the iShares Core MSCI EAFE ETF, trades at $96.52, up 0.33% on the day, but technical indicators signal a bearish trend with moving averages and oscillators in sell territory. The ETF provides exposure to developed markets outside North America, holding $196 billion in assets under management and offering a competitive expense ratio of 0.07%. Recent financial news highlights its role in international diversification, comparing favorably to peers on dividend yield and cost efficiency.
The outlook for IEFA is tempered by near-term technical weakness and broader market shifts away from concentrated U.S. tech exposure. Key risks include geopolitical tensions and interest rate uncertainty, but its low-cost structure and focus on established economies provide a defensive tilt for long-term investors seeking international diversification amid S&P 500 concentration concerns.
Lam Research (LRCX) trades at $318.84, down 3.24% on the day, with strong fundamentals including 29.06% net margin and consistent earnings beats. Technical indicators show a bearish short-term signal despite bullish moving averages, with key support at $314 and resistance at $329. Recent news highlights LRCX's positioning in AI-driven semiconductor equipment demand, with revenue growth accelerating to $18.44B in 2025.
Outlook remains positive with 78% analyst buy ratings and $375.68 consensus price target, representing 18% upside. Key risks include semiconductor cycle volatility and execution challenges in maintaining mid-40% operating margins. The stock offers growth exposure to AI infrastructure spending but faces competitive pressures in chip equipment markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core MSCI EAFE ETF
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
